Cocrystal Pharma, Inc.·4

Nov 28, 9:00 AM ET

FROST PHILLIP MD ET AL 4

4 · Cocrystal Pharma, Inc. · Filed Nov 28, 2025

Insider Transaction Report

Form 4
Period: 2025-11-26
FROST PHILLIP MD ET AL
Director10% Owner
Transactions
  • Purchase

    Common Stock

    2025-11-26$1.00/sh+1,500$1,5001,701,051 total(indirect: By Trust)
  • Purchase

    Common Stock

    2025-11-26$0.99/sh+2,500$2,4751,703,551 total(indirect: By Trust)
Holdings
  • Common Stock

    27,100
Footnotes (2)
  • [F1]These shares are held by Frost Gamma Investments Trust, of which Phillip Frost M.D., is the trustee. Frost Gamma L.P. is the sole and exclusive beneficiary of Frost Gamma Investments Trust. Dr. Frost is one of two limited partners of Frost Gamma L.P. The general partner of Frost Gamma L.P. is Frost Gamma, Inc., and the sole stockholder of Frost Gamma, Inc. is Frost-Nevada Corporation. Dr. Frost is the sole stockholder of Frost-Nevada Corporation. The Reporting Person disclaims beneficial ownership of the securities held by Frost Gamma Investments Trust except to the extent of any pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
  • [F2]Includes shares of common stock issuable upon vesting of restricted stock units.

Documents

1 file
  • 4
    ownership.xmlPrimary